Old Web
English
Sign In
Acemap
>
authorDetail
>
Michael Gautrois
Michael Gautrois
Grünenthal GmbH
Pharmacology
Pharmacokinetics
Cebranopadol
Analgesic
Medicine
5
Papers
122
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Second-generation TNFα turnover model for improved analysis of test compound interventions in LPS challenge studies.
2021
European Journal of Pharmaceutical Sciences
Julia Larsson
Edmund Hoppe
Michael Gautrois
Marija Cvijovic
Mats Jirstrand
Show All
Source
Cite
Save
Citations (0)
Clinical Pharmacokinetic Characteristics of Cebranopadol, a Novel First-in-Class Analgesic
2018
Clinical Pharmacokinectics
Elke Kleideiter
Chiara Piana
Shaonan Wang
Robert Nemeth
Michael Gautrois
Show All
Source
Cite
Save
Citations (12)
Correction to: Clinical Pharmacokinetic Characteristics of Cebranopadol, a Novel First-in-Class Analgesic
2018
Clinical Pharmacokinectics
Elke Kleideiter
Chiara Piana
Shaonan Wang
Robert Nemeth
Michael Gautrois
Show All
Source
Cite
Save
Citations (1)
Cebranopadol: a Novel Potent Analgesic Nociceptin/Orphanin FQ Peptide and Opioid Receptor Agonist
2014
Journal of Pharmacology and Experimental Therapeutics
Klaus Linz
Thomas Christoph
Thomas M. Tzschentke
Thomas Koch
Klaus Schiene
Michael Gautrois
Wolfgang Schröder
Babette Kögel
Horst Beier
Werner Englberger
Stefan Schunk
Jean De Vry
Ulrich Jahnel
Stefanie Frosch
Show All
Source
Cite
Save
Citations (109)
1